John Wiley & Sons (WLY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Feb, 2026Executive summary
Achieved or exceeded financial commitments for FY2025, with robust growth in core Research and Learning segments and significant margin expansion and cash flow improvement.
Drove strong results through AI licensing, data analytics, and knowledge services, with AI licensing revenue rising to $40M from $23M in FY2024.
Extended reach into the corporate market, secured new AI licensing agreements with major tech and pharmaceutical companies, and increased share repurchases by 34%.
Announced the 2025 Annual Meeting to be held virtually on September 25, 2025.
Voting matters and shareholder proposals
Shareholders will vote on the election of 10 directors (3 by Class A, 7 by Class B), ratification of PricewaterhouseCoopers LLP as independent auditors for FY2026, and an advisory say-on-pay vote on executive compensation.
Shareholders of record as of July 31, 2025, are eligible to vote.
Shareholder proposals and director nominations for the 2026 meeting must be submitted by specified deadlines.
Board of directors and corporate governance
Board consists of 10 members, 8 of whom are independent; all committees are 100% independent.
Board refreshment includes two new directors in 2025, with a focus on diversity, skills, and experience relevant to strategic objectives.
Annual board and committee self-evaluations, director education, and succession planning are emphasized.
Board leadership structure separates Chair and CEO roles; regular executive sessions held.
No related party transactions reported for FY2025.
Latest events from John Wiley & Sons
- Q3 delivered margin gains, strong cash flow, and high-end guidance reaffirmation.WLY
Q3 20266 Mar 2026 - Strategic transformation, leadership change, and strong governance define this year's proxy.WLY
Proxy Filing3 Feb 2026 - Shareholders to vote on directors, auditor, and executive pay at the September 2025 meeting.WLY
Proxy Filing3 Feb 2026 - Annual meeting to vote on directors, auditor ratification, and executive pay on Sept 26, 2024.WLY
Proxy Filing3 Feb 2026 - Learning and GenAI deals drive margin expansion and positive FY25 growth outlook.WLY
Q4 20243 Feb 2026 - Adjusted revenue up 6%, EPS up 74%, with divestitures and GenAI content fueling growth.WLY
Q1 202522 Jan 2026 - Adjusted revenue up 3%, margin and EPS growth, AI progress, and guidance reaffirmed.WLY
Q2 202511 Jan 2026 - Research and AI licensing drove margin gains and raised future margin targets.WLY
Q3 202529 Dec 2025 - Research and AI growth drove margin gains, offsetting Learning declines and market headwinds.WLY
Q2 20267 Dec 2025